USANA Health Sciences, Inc.USNANYSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank0
3Y CAGR-7.7%
5Y CAGR-10.3%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
-7.7%/yr
vs -4.7%/yr prior
5Y CAGR
-10.3%/yr
Consistent
Acceleration
-2.9pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | 10.27% | -11.2% |
| 2024 | 11.57% | -13.4% |
| 2023 | 13.37% | +2.5% |
| 2022 | 13.04% | -19.8% |
| 2021 | 16.26% | -8.2% |
| 2020 | 17.71% | +11.2% |
| 2019 | 15.93% | +0.6% |
| 2018 | 15.84% | +25.2% |
| 2017 | 12.65% | -16.3% |
| 2016 | 15.12% | - |